Parkinson's Disease Trial, Recruiting NCT06350617 Sponsor: Samsung Medical Center Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06350617
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease using a specific set of standard diagnostic guidelines known as the UK Parkinson's Disease Society Brain Bank Diagnostic Criteria
  • People whose Parkinson's disease falls within stages 2 to 4 on a standard scale used to measure how severe the condition is (called the Modified Hoehn and Yahr scale)
  • People who are able to walk on flat ground without using a walking aid such as a cane or walker
  • People aged 50 years or older
  • People who are willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • People who have conditions that make a brain stimulation treatment called rTMS unsafe for them, such as epilepsy, metal implants in the head, or a history of brain surgery
  • People who have a level of cognitive (thinking and memory) difficulty that falls below certain score thresholds on a standard test called the MoCA — the specific score cutoff depends on how many years of education the person has had (confirm with trial site)
  • People who have other neurological conditions at the same time, such as a spinal cord injury or a history of stroke
  • People who have a major mental health condition, such as severe depression, schizophrenia, or dementia
  • People whose Parkinson's symptoms include severe unpredictable medication fluctuations or severe uncontrolled movements, which the study team considers would make participation unsuitable
  • People who have any condition that makes having an MRI scan unsafe for them
  • People who are pregnant or breastfeeding
  • People who have declined to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Won Hyuk Chang, PhD, Samsung Medical Center

Phone: +82-2-3410-6068

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 February 2024
Est. completion
30 September 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Differences of Timed Up and Go Test (TUG)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov